US pharmaceutical giant Eli Lilly has reached a deal worth $2.75 billion with Insilico Medicine. Under the agreement, Lilly will bring AI-developed drugs to the global market, while Insilico will receive $115 million upfront, with the remainder tied to regulatory approvals and commercial milestones
​US pharmaceutical giant Eli Lilly has reached a deal worth $2.75 billion with Insilico Medicine. Under the agreement, Lilly will bring AI-developed drugs to the global market, while Insilico will receive $115 million upfront, with the remainder tied to regulatory approvals and commercial milestones by Soban News (international And National News)
